Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985163 · ClinicalTrials.gov registry record
Patient Reported Outcomes for Opioid Use Disorder
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 101
- Enrollment target
NCT03985163: Completed study, sponsored by Yale University.
NCT03985163 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 101 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03985163 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The goal of the project is to build a clinical data research infrastructure that will begin to enhance capacity to use electronic health record (EHR) data and patient reported outcomes measures (PROs) to conduct opioid related research in emergency departments (EDs). 200 adult patients with a history of non-medical opioid use, opioid use disorder, or acute opioid overdose will be enrolled and will be asked to complete three PRO surveys (baseline, 3 days post ED discharge, and 30 days post discharge).
Primary Outcome
The proportion of people who qualify for study criteria and enroll in the study
Interventions
- OTHER Patient Reported Outcomes Electronic Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2019-06-07 |
| Est. Completion | 2020-02-16 |
What the finished NCT03985163 record still lists
NCT03985163 is an observational study that tracks outcomes without assigning an intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Patient Reported Outcomes Electronic Survey is the first listed.
NCT03985163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03985163 about?
NCT03985163 is a clinical study titled "Patient Reported Outcomes for Opioid Use Disorder". The goal of the project is to build a clinical data research infrastructure that will begin to enhance capacity to use electronic health record (EHR) data and patient reported outcomes measures (PROs) to conduct opioid related research in emergency departments (EDs). 200 adult patients with a histor...
What is the current status of trial NCT03985163?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2019-06-07. Estimated completion is 2020-02-16.
What interventions are being tested in trial NCT03985163?
The interventions under investigation include: Patient Reported Outcomes Electronic Survey (OTHER).
Who is sponsoring clinical trial NCT03985163?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI